Hexa-BODIPY-cyclotriphosphazene based nanoparticle for NIR fluorescence/photoacoustic dual-modal imaging and photothermal cancer therapy
SCIE
SCOPUS
- Title
- Hexa-BODIPY-cyclotriphosphazene based nanoparticle for NIR fluorescence/photoacoustic dual-modal imaging and photothermal cancer therapy
- Authors
- Kwon, Nahyun; Kim, Kwang H.; Park, Sinyoung; Cho, Yejin; Park, Eun-Yeong; Lim, Junha; Çetindere, Seda; Tümay, Süreyya Oğuz; KIM, WON JONG; Li, Xingshu; Nam, Ki Taek; Kim, Chulhong; Yeşilot, Serkan; Yoon, Juyoung
- Date Issued
- 2022-11
- Publisher
- Pergamon Press Ltd.
- Abstract
- © 2022 Elsevier B.V.Theranostic, which integrates the diagnosis and tumor treatment in tandem, is an emerging strategy in cancer treatment. Here, we report a novel and unique theranostic nanoparticle, HBCP NP, based on hexa-BODIPY cyclophosphazene (HBCP). Due to the unique bulky molecular structure of HBCP, this nanoparticle can simultaneously perform near-infrared (NIR) fluorescence imaging and photoacoustic imaging (PAI). Interestingly, since reactive oxygen species (ROS) generation of HBCP NPs is completely inhibited, ‘safe’ fluorescence imaging is possible without the risk of cell damage even under laser irradiation. Finally, NIR fluorescence imaging and PAI in 4T1 tumor-bearing mice demonstrated selective accumulation of HBCP NPs at tumor sites. In addition, HBCP NPs exhibited excellent photothermal effects under high-power laser irradiation, achieving effective tumor growth inhibition.
- URI
- https://oasis.postech.ac.kr/handle/2014.oak/116171
- DOI
- 10.1016/j.bios.2022.114612
- ISSN
- 0956-5663
- Article Type
- Article
- Citation
- Biosensors and Bioelectronics, vol. 216, page. 114612, 2022-11
- Files in This Item:
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.